Ralph Landau

Ralph is a highly skilled and experienced executive with a career spanning over 30 years leading R&D, compliance, manufacturing, and operations across a variety of pharmaceutical companies including Sandoz, Novartis, and Merck. He has led the commercialization of over 50 products covering a number of dosage forms, including Veregen, the first-ever botanical drug approved by the FDA. Formally trained as a Ph.D. chemical engineer, Ralph has spent significant time in both generic and branded businesses and has a deep understanding of pharmaceutical drugs’ development & manufacturing processes.